ASTM F 1904 : 1998 : R2003
|
Standard Practice for Testing the Biological Responses to Particles In Vivo
|
ASTM E 1262 : 1988 : R2003
|
Standard Guide for Performance of the Chinese Hamster Ovary Cell/Hypoxanthine Guanine Phosphoribosyl Transferase Gene Mutation Assay
|
ASTM F 1983 : 1999 : R2008
|
Standard Practice for Assessment of Compatibility of Absorbable/Resorbable Biomaterials for Implant Applications
|
ASTM F 1877 : 2005
|
Standard Practice for Characterization of Particles
|
ASTM F 1439 : 2003
|
Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials
|
ASTM F 1027 : 1986 : R2012
|
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices
|
ASTM F 1983 : 1999 : R2003
|
Standard Practice for Assessment of Compatibiltiy of Absorbable/Resorbable Biomaterials for Implant Applications
|
ASTM F 1984 : 1999 : R2008
|
Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials
|
ASTM F 2065 : 2000 : EDT 1
|
Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials
|
ASTM F 1983 : 2023
|
Standard Practice for Assessment of Selected Tissue Effects of Absorbable Biomaterials for Implant Applications
|
ASTM F 2382 : 2004 : R2010
|
Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT)
|
ASTM F 1904 : 1998 : EDT 1
|
Standard Practice for Testing the Biological Responses to Particles In Vivo
|
ASTM F 2382 : 2004 : EDT 1
|
Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT)
|
ASTM F 763 : 2022
|
Standard Practice for Short-Term Intramuscular Screening of Implantable Medical Device Materials
|
ASTM F 2148 : 2006 : REV A
|
Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
|
ASTM F 1903 : 2010
|
Standard Practice for Testing For Biological Responses to Particles <i>In Vitro</i>
|
ASTM E 1262 : 1988 : R1996
|
Standard Guide for Performance of the Chinese Hamster Ovary Cell/Hypoxanthine Guanine Phosphoribosyl Transferase Gene Mutation Assay
|
ASTM F 763 : 2004 : R2016
|
Standard Practice for Short-Term Screening of Implant Materials
|
ASTM F 1904 : 2023
|
Standard Guide for Testing the Biological Responses to Medical Device Particulate Debris and Degradation Products <emph type="ital">in vivo</emph>
|
ASTM F 2382 : 2017
|
Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT)
|
ASTM F 2148 : 2013
|
Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
|
ASTM F 1439 : 2003 : R2008
|
Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials
|
ASTM F 1904 : 2014
|
Standard Practice for Testing the Biological Responses to Particles <emph type="bdit" >in vivo</emph>
|
ASTM F 2065 : 2000 : R2010
|
Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials (Withdrawn 2016)
|
ASTM F 2148 : 2007
|
Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
|
ASTM F 1027 : 1986 : R1995 : EDT 1
|
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices
|
ASTM F 2148 : 2018
|
Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
|
ASTM F 2148 : 2007 : R2012
|
Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
|
ASTM F 2148 : 2007 : EDT 1
|
Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
|
ASTM F 1984 : 1999 : R2018
|
Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials
|
ASTM F 1439 : 2003 : R2018
|
Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials
|
ASTM E 1262 : 1988 : R2013
|
Standard Guide for Performance of Chinese Hamster Ovary Cell/Hypoxanthine Guanine Phosphoribosyl Transferase Gene Mutation Assay
|
ASTM E 1262 : 1988 : R2018
|
Standard Guide for Performance of Chinese Hamster Ovary Cell/Hypoxanthine Guanine Phosphoribosyl Transferase Gene Mutation Assay
|
ASTM F 756 : 2008
|
Standard Practice for Assessment of Hemolytic Properties of Materials
|
ASTM F 1408 : 1997
|
Standard Practice for Subcutaneous Screening Test for Implant Materials
|
ASTM F 1408 : 1997 : R2008
|
Standard Practice for Subcutaneous Screening Test for Implant Materials
|
ASTM F 1984 : 1999
|
Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials
|
ASTM F 1904 : 1998 : R2008
|
Standard Practice for Testing the Biological Responses to Particles <i>in vivo</i>
|
ASTM F 2148 : 2001
|
Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
|
ASTM F 1903 : 1998
|
Standard Practice for Testing for Biological Responses to Particles In Vitro
|
ASTM F 1408 : 1997 : R2002 : EDT 1
|
Standard Practice for Subcutaneous Screening Test for Implant Materials
|
ASTM F 1984 : 1999 : R2003
|
Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials
|
ASTM F 2147 : 2001 : R2016
|
Standard Practice for Guinea Pig: Split Adjuvant and Closed Patch Testing for Contact Allergens
|
ASTM F 981 : 2004 : R2016
|
Standard Practice for Assessment of Compatibility of Biomaterials for Surgical Implants with Respect to Effect of Materials on Muscle and Insertion into Bone
|
ASTM F 763 : 1999
|
Standard Practice for Short-Term Screening of Implant Materials
|
ASTM F 2065 : 2000 : R2006
|
Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials
|
ASTM F 1439 : 2002
|
Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials
|
ASTM F 2382 : 2004
|
Standard Test Method for Assessment of Intravascular Medical Device Materials on Partial Thromboplastin Time (PTT)
|
ASTM F 1903 : 2018
|
Standard Practice for Testing for Cellular Responses to Particles <emph type="bdit" >in vitro</emph>
|
ASTM F 2147 : 2001
|
Standard Practice for Guinea Pig: Split Adjuvant and Closed Patch Testing for Contact Allergens
|
ASTM F 1877 : 2016
|
Standard Practice for Characterization of Particles
|
ASTM F 1877 : 1998
|
Standard Practice for Characterization of Particles
|
ASTM F 1027 : 1986 : R2017
|
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices (Withdrawn 2023)
|
ASTM F 1983 : 2014
|
Standard Practice for Assessment of Selected Tissue Effects of Absorbable Biomaterials for Implant Applications
|
ASTM F 1027 : 1986 : R2007
|
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices
|
ASTM F 1877 : 2005 : R2010
|
Standard Practice for Characterization of Particles
|
ASTM F 1877 : 2005 : EDT 1
|
Standard Practice for Characterization of Particles
|
ASTM F 2382 : 2017 : EDT 1
|
Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT)
|
ASTM F 1984 : 1999 : R2013
|
Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials
|
ASTM F 1027 : 1986 : R2002
|
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices
|
ASTM E 1262 : 1988 : R2008
|
Standard Guide for Performance of Chinese Hamster Ovary Cell/Hypoxanthine Guanine Phosphoribosyl Transferase Gene Mutation Assay
|
ASTM F 2147 : 2001 : R2006
|
Standard Practice for Guinea Pig: Split Adjuvant and Closed Patch Testing for Contact Allergens
|
ASTM F 1439 : 1992 : R1996
|
Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials
|
ASTM F 1439 : 2003 : R2013
|
Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials
|
ASTM F 2147 : 2001 : R2010
|
Standard Practice for Guinea Pig: Split Adjuvant and Closed Patch Testing for Contact Allergens
|
ASTM F 1983 : 1999
|
Standard Practice for Assessment of Compatibiltiy of Absorbable/Resorbable Biomaterials for Implant Applications
|
ASTM F 1408 : 1997 : R2013
|
Standard Practice for Subcutaneous Screening Test for Implant Materials
|
ASTM F 981 : 2023
|
Standard Practice for Assessment of Muscle and Bone Tissue Responses to Long-Term Implantable Materials Used in Medical Devices
|
ASTM F 2382 : 2018
|
Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT)
|